Equity Research, Broker Reports, and media content on RECORDATI SPA

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about RECORDATI SPA
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on RECORDATI SPA. We currently have 0 research reports from 0 professional analysts.

Open
34.2
Volume
1.8m
Range
33.4/34.3
Market Cap
7,158,353,857m
52 Week
21.7/34.4
Date Source Announcement
22May17 07:02 GNW RECORDATI ACQUIRES RIGHTS TO ASTRAZENECA'S METOPROLOL BASED TREATMENTS IN EUROPE
04May17 11:56 GNW RECORDATI: EXCELLENT RESULTS IN THE FIRST QUARTER 2017. CONTINUED GROWTH IN SALES +13.1%, OPERATING INCOME +19.0%, NET INCOME +19.9%
11Apr17 13:11 GNW RECORDATI: SHAREHOLDERS APPROVE THE 2016 ACCOUNTS. DIVIDEND € 0.70 PER SHARE (+16.7% vs 2015)
01Mar17 11:39 GNW RECORDATI: BOARD APPROVES THE 2016 ACCOUNTS. SALES € 1,153.9 MILLION (+10.1%), OPERATING INCOME € 327.4 MILLION (+17.6%) AND NET INCOME € 237.4 MILLION (+19.4%). 2016 DIVIDEND € 0.70 (+16.7%)
27Feb17 08:01 GNW RECORDATI SIGNS AN EXCLUSIVE LICENSE AGREEMENT WITH THE MEYER HOSPITAL IN FLORENCE
09Feb17 11:05 GNW RECORDATI: PRELIMINARY 2016 RESULTS CONFIRM CONTINUED GROWTH OF REVENUES AND PROFITABILITY. NEW THREE YEAR BUSINESS PLAN PRESENTED
01Feb17 08:05 GNW RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY AND SPECIALIZED PRESS IN MILAN
  • Frequency of research reports

     

  • Research reports on

    RECORDATI SPA

  • Providers covering

    RECORDATI SPA